SLEEPCLINIC.BE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SLEEPCLINIC.BE
Largest movements
- Intangible fixed assets +€9,844
up €9,844 (+93.3%), from €10,556 to €20,400
- Cash +€7,665
up €7,665 (+330%), from €2,320 to €9,985
mainly Other debts (+€13,838) and Depreciation (+€6,422)
- Tangible fixed assets -€754
down €754 (-47.8%), from €1,576 to €822
- Deferred charges and accrued income -€448
down €448 (-80.9%), from €553 to €106
- Other debts +€13,838
up €13,838 (+1,074%), from €1,289 to €15,126
- Profit (loss) carried forward +€5,708
up €5,708 (+111%), from €5,129 to €10,836
- Trade debts -€4,751
no longer reported in 2025 (was €4,751)
- Tax, wage and social debts +€1,513
up €1,513 (+113%), from €1,338 to €2,851
- Depreciation +€4,485
up €4,485 (+232%), from €1,937 to €6,422
- Gross operating margin +€4,405
up €4,405 (+43.8%), from €10,066 to €14,471
- Other operating charges +€257
up €257 (+66.5%), from €387 to €645
- Taxes +€175
up €175 (+13.1%), from €1,338 to €1,513
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €15,006 | €31,313 | +€16,307 | +109% |
| Fixed assets | 21/28 | €12,132 | €21,222 | +€9,090 | +74.9% |
| Intangible fixed assets | 21 | €10,556 | €20,400 | +€9,844 | +93.3% |
| Tangible fixed assets | 22/27 | €1,576 | €822 | -€754 | -47.8% |
| Plant, machinery and equipment | 23 | €1,576 | €822 | -€754 | -47.8% |
| Current assets | 29/58 | €2,874 | €10,091 | +€7,217 | +251% |
| Cash at bank and in hand | 54/58 | €2,320 | €9,985 | +€7,665 | +330% |
| Deferred charges and accrued income | 490/1 | €553 | €106 | -€448 | -80.9% |
| Total equity and liabilities | 10/49 | €15,006 | €31,313 | +€16,307 | +109% |
| Equity | 10/15 | €7,629 | €13,336 | +€5,708 | +74.8% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €5,129 | €10,836 | +€5,708 | +111% |
| Amounts payable | 17/49 | €7,377 | €17,977 | +€10,600 | +144% |
| Amounts payable within one year | 42/48 | €7,377 | €17,977 | +€10,600 | +144% |
| Trade debts | 44 | €4,751 | - | -€4,751 | |
| Suppliers | 440/4 | €4,751 | - | -€4,751 | |
| Taxes, remuneration and social security | 45 | €1,338 | €2,851 | +€1,513 | +113% |
| Taxes | 450/3 | €1,338 | €2,851 | +€1,513 | +113% |
| Other amounts payable | 47/48 | €1,289 | €15,126 | +€13,838 | +1,074% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,937 | €6,422 | +€4,485 | +232% |
| Other operating charges | 640/8 | €387 | €645 | +€257 | +66.5% |
| Gross operating margin | 9900 | €10,066 | €14,471 | +€4,405 | +43.8% |
| Operating profit (loss) | 9901 | €7,742 | €7,405 | -€337 | -4.4% |
| Financial income | 75/76B | €20 | - | -€20 | |
| Recurring financial income | 75 | €20 | - | -€20 | |
| Financial charges | 65/66B | €161 | €184 | +€23 | +14.3% |
| Recurring financial charges | 65 | €161 | €184 | +€23 | +14.3% |
| Profit (loss) for the period before taxes | 9903 | €7,601 | €7,221 | -€380 | -5.0% |
| Income taxes | 67/77 | €1,338 | €1,513 | +€175 | +13.1% |
| Profit (loss) for the period | 9904 | €6,264 | €5,708 | -€556 | -8.9% |
| Profit (loss) for the period to be appropriated | 9905 | €6,264 | €5,708 | -€556 | -8.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.